Evaluation of Conjunctivitis Clinical Practice Guidelines: An Analysis of Quality and Treatment Proposals

<i>Introduction:</i> Conjunctivitis is an inflammation of the conjunctiva, commonly caused by bacteria, viruses, or allergens. It represents a significant portion of healthcare visits worldwide and is often self-limiting. However, it can cause considerable discomfort and lead to economic burdens, including medical expenses and lost productivity. Therefore, it is essential to develop and implement clear clinical practice guidelines to ensure appropriate management and avoid unnecessary interventions. Objective: This study aimed to identify and evaluate clinical practice guidelines for the management of acute primary conjunctivitis, focusing on their quality and practical applicability. <i>Methods: </i>A systematic search was conducted across multiple databases to identify relevant clinical practice guidelines. The quality of each guideline was assessed using an established evaluation method that examines six key domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. <i>Results:</i> The search identified ten clinical practice guidelines, of which four were considered suitable for recommendation. The guidelines received the lowest scores in applicability and rigor of development, while clarity of presentation and editorial independence received the highest ratings. All guidelines emphasized non-pharmacological therapy as the preferred first-line treatment. <i>Conclusion</i>: Although four guidelines were recommended, their overall quality fell short of expectations, particularly in applicability and long-term intervention follow-up. These findings underscore the need for improvements to enhance the practical implementation and effectiveness of treatment strategies.